Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB) (Q2896292)
Jump to navigation
Jump to search
Project Q2896292 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB) |
Project Q2896292 in Portugal |
Statements
235,778.0 Euro
0 references
471,555.0 Euro
0 references
50.0 percent
0 references
20 November 2019
0 references
31 August 2022
0 references
LIFEWELL - PHARMACEUTICAL & HEALTHCARE, LDA
0 references
40°50'20.44"N, 8°28'40.01"W
0 references
O presente projeto tem como objetivo o reforço das competências da LifeWell nos domínios da qualificação, da investigação e desenvolvimento e inovação (I&D&I) através da contratação de recursos altamente qualificados que contribuem para a consecução da estratégia de inovação, diversificação e crescimento sustentável da empresa, nos segmentos dos suplementos alimentares e medicamentos sujeitos a receita médica (MSRM). (Portuguese)
0 references
The present project aims to strengthen Lifewell’s skills in the areas of qualification, research and development and innovation (I &D&I) by hiring highly qualified resources that contribute to achieving the company’s innovation, diversification and sustainable growth strategy in the food supplements and prescription drugs (MSRM) segments. (English)
8 July 2021
0 references
Ce projet vise à renforcer les compétences de Lifewell dans les domaines de la qualification, de la recherche et du développement et de l’innovation (I&D&I) en soustrayant des ressources hautement qualifiées qui contribuent à la réalisation de la stratégie d’innovation, de diversification et de croissance durable de l’entreprise, dans les segments des compléments alimentaires et des médicaments sur ordonnance (MSRM). (French)
5 December 2021
0 references
Dieses Projekt zielt darauf ab, die Kompetenzen von Lifewell in den Bereichen Qualifikation, Forschung und Entwicklung und Innovation (I&D&I) zu stärken, indem hochqualifizierte Ressourcen zur Verwirklichung der Innovation, Diversifizierung und nachhaltigen Wachstumsstrategie des Unternehmens in den Segmenten Nahrungsergänzungsmittel und verschreibungspflichtige Arzneimittel (MSRM) vergeben werden. (German)
13 December 2021
0 references
Oliveira de Azeméis
0 references
Identifiers
NORTE-06-3559-FSE-000059
0 references